Pancreas-derived plasminogen activator inhibitor

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S338000

Reexamination Certificate

active

06893870

ABSTRACT:
The present invention relates to a novel member of the plasminogen activator inhibitor protein family. In particular, isolated nucleic acid molecules are provided encoding the pancreas-derived plasminogen activator inhibitor protein. Pancreas-derived plasminogen activator inhibitor polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to methods for treating physiologic and pathologic disease conditions and diagnostic methods for detecting pathologic disorders.

REFERENCES:
patent: 4923807 (1990-05-01), Webb et al.
patent: 5470970 (1995-11-01), Sager et al.
patent: 5804376 (1998-09-01), Braxton et al.
patent: 6303338 (2001-10-01), Ni et al.
patent: 6649738 (2003-11-01), Ni et al.
patent: WO-9634957 (1996-11-01), None
Barton, G.J., “Protein sequence alignment and database scanning,” in: Protein Structure Prediction, A Practical Approach, Sternberg, M.J.E., ed., IRL Press at Oxford University Press, Oxford, UK, pp. 31-63 (Aug. 1996).
Carrell, R.W. et al., “The Serpins; Evolution and Adaptation in a Family of Protease Inhibitors,”Cold Spring Harbor Symp. Quant. Biol.52:527-535, Cold Spring Harbor Laboratory (1987).
Cronshagen, U. et al., “A novel protein expressed exclusively in pancreatic cells is proposed to be a serpin,” Abstract No. 247,Eur. J. Cell Biol.94:83, Nature Publishing Group (1993).
Cunningham, B.C. and Wells, J.A., “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis,”Science244:1081-1085, American Association for the Advancement of Science (1989).
Fazioli, F. and Blasi, F., “Urokinase-type plasminogen activator and its receptor; new targets for anti-metastatic therapy?,”TiPS15:25-29, Elsevier Science (1994).
George, D.G. et al., “Current Methods in Sequence Comparison and Analysis,” in: Macromolecular Sequencing and Synthesis, Selected Methods and Applications, D.H. Schlesinger, ed., Alan R. Liss, Inc. New York, NY, pp. 127-149 (1988).
Ginsburg, D. et al., “cDNA Cloning of Human Plasminogen Activator-Inhibitor from Endothelial Cells,”J. Clin. Invest.78:1673-1680, American Society for Clinical Investigation (1986).
Krishnamurti, C. et al., “Stimulation Of Plasminogen Activator Inhibitor Activity In Human Monocytes Infected With Dengue Virus,”Am. J. Trop. Med. Hyg.40:102-107, American Society of Tropical Medicine and Hygiene (1989).
Kruithof, E.K.O. et al., “Biological and Clinical Aspects of Plasminogen Activator Inhibitor Type 2,”Blood86:4007-4024, Journal of the American Society of Hematology (Dec. 1995).
Leiper, K. et al., “Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease,”J. Clin. Pathol.47:214-217, BMJ Publishing Group (1994).
Ngo, J.T. et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox,” in: The Protein Folding Problem and Tertiary Strucure Prediction, Mertz, Jr., K. and Le Grand, S., eds., Birkhauser, Boston, Massachusetts, pp. 491-495 (1994).
Robson, R. and Garnier, J., eds., “Modern ideas and notations relating to primary structure,” in: Introduction to Proteins and Protein Engineering, Elsevier, Amsterdam, Holland pp. 41-43 (1986).
Rudinger, J., “Characteristics of the amino acids as components of a peptide hormone sequence,” in: Peptide Hormones, Parsons, J.A., eds., University Park Press, Baltimore, Maryland, pp. 5-7 (1976).
Sprecher, C.A. et al., “Molecular Cloning, Expression, and Partial Characterization of Two Novel Members of the Ovalbumin Family of Serine Proteinase Inhibitors,”J. Biol. Chem.270:29854-29861, American Society for Biochemistry and Molecular Biology (Dec. 1995).
Sun, J. et al., “Gene Structure, Chromosomal Localization, and Expression of the Murine Homologue of Human Proteinase Inhibitor 6 (Pl-6) Suggests Divergence of Pl-6 from the Ovalbumin Serpins,”J. Biol. Chem.270:16089-16096, American Society for Biochemistry and Molecular Biology (Jul. 1995).
Urano, T. et al., “A substrate-like form of plasminogen-activator-inhibitor type 1,”Eur. J. Biochem.209:985-992, Federation of European Biochemical Societies (1992).
Wells, J.A., “Additivity of Mutational Effects in Proteins,”Biochem.29:8509-8516, American Chemical Society (1990).
Genbank Report, Accession No. Z30585, submitted by Cronshagen, U. et al. (1994).
Genbank Report, Accession No. AAA6003, submitted by Ginsburg, D. et al. (Jan. 1995).
Genbank Report, Accession No. X16383, submitted by Sawdey, M.S. (Feb. 1995).
Genbank Report, Accession No. D13909, submitted by Mimuro et al. (Nov. 1995).
NCBI Entrez, GenBank Report, Accession No. T52685, from Hillier, L. et al. (Feb. 1995)
NCBI Entrez, GenBank Report, Accession No. F07041, from Auffray, C. et al. (Feb. 1995).
NCBI Entrez, GenBank Report, Accession No. D58484, from Fujiwara, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report, Accession No. H81869, from Hillier, L. et al. (Nov. 1995).
NCBI Entrez, GenBank Report, Accession No. H82168, from Hillier, L. et al. (Nov. 1995).
NCBI Entrez, GenBank Report, Accession No. D27259, from Kohara, Y. et al. (Nov. 1995).
NCBI Entrez, GenBank Report, Accession No. N34066, from Hillier, L. et al. (Jan. 1996).
NCBI Entrez, GenBank Report, Accession No. N41961, from Hillier, L. et al. (Jan. 1996).
NCBI Entrez, GenBank Report, Accession No. N86663, from Liew, C.C. (Apr. 1996).
NCBI Entrez, GenBank Report, Accession No. C18938, from Fujiwara, T. et al. (Oct. 1996).
NCBI Entrez, GenBank Report, Accession No. C18122, from Fujiwara, T. et al. (Oct. 1996).
NCBI Entrez, GenBank Report, Accession No. AA091273, from Liew, C.C. (Oct. 1996).
NCBI Entrez, GenBank Report, Accession No. AA104570, from Marra, M. et al. (Oct. 1996).
NCBI Entrez, GenBank Report, Accession No. AA147887, from Hillier, L. et al. (Dec. 1996).
NCBI Entrez, GenBank Report, Accession No. AA147909, from Hillier, L. et al. (Dec. 1996).
NCBI Entrez, GenBank Report, Accession No. AA147917, from Hillier, L. et al. (Dec. 1996).
NCBI Entrez, GenBank Report, Accession No. AA168365, from Marra, M. et al. (Feb. 1997).
NCBI Entrez, GenBank Report, Accession No. AA117151, from Marra, M. et al. (Feb. 1997).
NCBI Entrez, GenBank Report, Accession No. AA276326, from Marra, M. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA303966, from Adams, M.D. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA296389, from Adams, M.D. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA296506, from Adams, M.D. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA317566, from Adams, M.D. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA372832, from Adams, M.D. et al. (Apr. 1997).
NCBI Entrez, GenBank Report, Accession No. AA409232, from Ko, M.S.H. et al. (May 1997).
NCBI Entrez, GenBank Report, Accession No. AA045132, from Hillier, L. et al. (May 1997).
NCBI Entrez, GenBank Report, Accession No. AA473834, from Marra, M. et al. (Jun. 1997).
NCBI Entrez, GenBank Report, Accession No. H09005, from Hillier, L. et al. (Jun. 1997).
NCBI Entrez, GenBank Report, Accession No. AA544064, from Marra, M. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA146811, from Hillier, L. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA242969, from Hillier, L. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA562720, from Marra, M. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA542814, from NCI-CGAP (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA571334, from Marra, M. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. C31835, from Kohara, Y. et al. (Sep. 1997).
NCBI Entrez, GenBank Report, Accession No. AA589090, from Marra, M. et al. (Sep. 1997).
NCBI Entrez, GenBank Report, Accession No. H52450, from Hillier, L. et al. (Sep. 1995).
NCBI Entrez, GenBank Report, Accession No. AA5

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pancreas-derived plasminogen activator inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pancreas-derived plasminogen activator inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreas-derived plasminogen activator inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3457880

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.